SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4k2a'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2COI_A_GBNA420_1
(BRANCHED CHAIN
AMINOTRANSFERASE 1,
CYTOSOLIC)
4k2a HALOALKANE
DEHALOGENASE

(Bradyrhizobium
elkanii)
5 / 10 GLY A 105
THR A 106
ALA A 101
TYR A 233
VAL A 120
None
1.38A 2coiA-4k2aA:
undetectable
2coiB-4k2aA:
undetectable
2coiA-4k2aA:
19.95
2coiB-4k2aA:
19.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2COI_B_GBNB420_1
(BRANCHED CHAIN
AMINOTRANSFERASE 1,
CYTOSOLIC)
4k2a HALOALKANE
DEHALOGENASE

(Bradyrhizobium
elkanii)
5 / 10 TYR A 233
VAL A 120
GLY A 105
THR A 106
ALA A 101
None
1.36A 2coiA-4k2aA:
undetectable
2coiB-4k2aA:
undetectable
2coiA-4k2aA:
19.95
2coiB-4k2aA:
19.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2COJ_A_GBNA420_1
(BRANCHED CHAIN
AMINOTRANSFERASE 1,
CYTOSOLIC)
4k2a HALOALKANE
DEHALOGENASE

(Bradyrhizobium
elkanii)
5 / 11 GLY A 105
THR A 106
ALA A 101
TYR A 233
VAL A 120
None
1.39A 2cojA-4k2aA:
undetectable
2cojB-4k2aA:
undetectable
2cojA-4k2aA:
19.95
2cojB-4k2aA:
19.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2COJ_B_GBNB420_1
(BRANCHED CHAIN
AMINOTRANSFERASE 1,
CYTOSOLIC)
4k2a HALOALKANE
DEHALOGENASE

(Bradyrhizobium
elkanii)
5 / 9 TYR A 233
VAL A 120
GLY A 105
THR A 106
ALA A 101
None
1.38A 2cojA-4k2aA:
undetectable
2cojB-4k2aA:
undetectable
2cojA-4k2aA:
19.95
2cojB-4k2aA:
19.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PYM_A_1UNA1001_3
(PROTEASE RETROPEPSIN)
4k2a HALOALKANE
DEHALOGENASE

(Bradyrhizobium
elkanii)
3 / 3 ASP A 163
ASN A 164
THR A 147
None
0.69A 2pymB-4k2aA:
undetectable
2pymB-4k2aA:
14.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XFH_A_CL6A1413_1
(ERYTHROMYCIN B/D
C-12 HYDROXYLASE)
4k2a HALOALKANE
DEHALOGENASE

(Bradyrhizobium
elkanii)
4 / 6 ALA A 227
ALA A 229
THR A 257
PHE A 254
None
1.06A 2xfhA-4k2aA:
undetectable
2xfhA-4k2aA:
24.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3FBW_A_BEZA501_0
(HALOALKANE
DEHALOGENASE)
4k2a HALOALKANE
DEHALOGENASE

(Bradyrhizobium
elkanii)
8 / 9 ASN A  38
ASP A 103
TRP A 104
PHE A 148
PHE A 167
LEU A 208
HIS A 271
TYR A 272
CL  A 501 (-4.3A)
CL  A 501 ( 4.7A)
CL  A 501 (-4.4A)
None
CL  A 501 (-4.7A)
None
None
None
0.35A 3fbwA-4k2aA:
46.1
3fbwA-4k2aA:
48.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3FBW_A_BEZA501_0
(HALOALKANE
DEHALOGENASE)
4k2a HALOALKANE
DEHALOGENASE

(Bradyrhizobium
elkanii)
5 / 9 ASP A 103
TRP A 104
PHE A 138
LEU A 208
HIS A 271
CL  A 501 ( 4.7A)
CL  A 501 (-4.4A)
None
None
None
1.25A 3fbwA-4k2aA:
46.1
3fbwA-4k2aA:
48.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HZN_D_ACTD229_0
(OXYGEN-INSENSITIVE
NAD(P)H
NITROREDUCTASE)
4k2a HALOALKANE
DEHALOGENASE

(Bradyrhizobium
elkanii)
4 / 4 ASP A   6
GLY A  25
LYS A   6
GLU A  23
None
1.02A 3hznD-4k2aA:
undetectable
3hznD-4k2aA:
23.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ITA_D_AICD501_1
(D-ALANYL-D-ALANINE
CARBOXYPEPTIDASE
DACC)
4k2a HALOALKANE
DEHALOGENASE

(Bradyrhizobium
elkanii)
3 / 3 PRO A 209
PHE A  78
ALA A 107
None
0.67A 3itaD-4k2aA:
undetectable
3itaD-4k2aA:
23.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3S_D_9PLD1_1
(CYTOCHROME P450 2A13)
4k2a HALOALKANE
DEHALOGENASE

(Bradyrhizobium
elkanii)
4 / 8 PHE A 125
PHE A 110
ALA A 229
THR A 257
None
0.94A 3t3sD-4k2aA:
undetectable
3t3sD-4k2aA:
20.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BQF_A_QPSA951_1
(ALPHA-GLUCAN
PHOSPHORYLASE 2,
CYTOSOLIC)
4k2a HALOALKANE
DEHALOGENASE

(Bradyrhizobium
elkanii)
4 / 6 MET A 160
GLY A 157
ARG A 170
GLU A 146
None
1.46A 4bqfA-4k2aA:
4.3
4bqfA-4k2aA:
16.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EAH_F_ACTF402_0
(ACTIN, ALPHA
SKELETAL MUSCLE)
4k2a HALOALKANE
DEHALOGENASE

(Bradyrhizobium
elkanii)
3 / 3 PHE A  79
ASP A  86
ARG A 115
None
0.87A 4eahF-4k2aA:
undetectable
4eahF-4k2aA:
20.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EAH_G_ACTG401_0
(ACTIN, ALPHA
SKELETAL MUSCLE)
4k2a HALOALKANE
DEHALOGENASE

(Bradyrhizobium
elkanii)
3 / 3 PHE A  79
ASP A  86
ARG A 115
None
0.87A 4eahG-4k2aA:
undetectable
4eahG-4k2aA:
20.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJG_A_NCTA501_1
(CYTOCHROME P450 2A13)
4k2a HALOALKANE
DEHALOGENASE

(Bradyrhizobium
elkanii)
4 / 7 PHE A 128
PHE A 125
ALA A 255
LEU A 228
None
1.06A 4ejgA-4k2aA:
undetectable
4ejgA-4k2aA:
20.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4F5Z_A_BEZA302_0
(HALOALKANE
DEHALOGENASE)
4k2a HALOALKANE
DEHALOGENASE

(Bradyrhizobium
elkanii)
8 / 8 ASN A  38
ASP A 103
TRP A 104
PHE A 167
VAL A 171
LEU A 208
HIS A 271
TYR A 272
CL  A 501 (-4.3A)
CL  A 501 ( 4.7A)
CL  A 501 (-4.4A)
CL  A 501 (-4.7A)
None
None
None
None
0.35A 4f5zA-4k2aA:
46.5
4f5zA-4k2aA:
48.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4F5Z_A_BEZA302_0
(HALOALKANE
DEHALOGENASE)
4k2a HALOALKANE
DEHALOGENASE

(Bradyrhizobium
elkanii)
4 / 8 ASP A 103
TRP A 104
PHE A 148
HIS A 271
CL  A 501 ( 4.7A)
CL  A 501 (-4.4A)
None
None
1.11A 4f5zA-4k2aA:
46.5
4f5zA-4k2aA:
48.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KR4_C_AICC401_1
(OUTER MEMBRANE
PROTEIN F)
4k2a HALOALKANE
DEHALOGENASE

(Bradyrhizobium
elkanii)
4 / 8 TYR A  43
ARG A  46
GLU A 182
ARG A 178
None
1.41A 4kr4C-4k2aA:
undetectable
4kr4C-4k2aA:
22.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LRH_D_FOLD301_1
(FOLATE RECEPTOR
ALPHA)
4k2a HALOALKANE
DEHALOGENASE

(Bradyrhizobium
elkanii)
3 / 3 HIS A 139
TRP A 135
SER A 175
None
1.21A 4lrhD-4k2aA:
undetectable
4lrhD-4k2aA:
16.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F1A_B_SALB601_1
(PROSTAGLANDIN G/H
SYNTHASE 2)
4k2a HALOALKANE
DEHALOGENASE

(Bradyrhizobium
elkanii)
4 / 7 LEU A 273
GLY A 269
ALA A 268
SER A 241
None
0.89A 5f1aB-4k2aA:
undetectable
5f1aB-4k2aA:
19.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VCG_A_08YA602_1
(CYTOCHROME P450 3A4)
4k2a HALOALKANE
DEHALOGENASE

(Bradyrhizobium
elkanii)
5 / 12 ASP A 142
PHE A 148
PHE A 138
THR A 218
ALA A 211
None
1.17A 5vcgA-4k2aA:
undetectable
5vcgA-4k2aA:
19.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ECF_I_DVAI3010_0
(VLM2
DODECADEPSIPEPTIDE)
4k2a HALOALKANE
DEHALOGENASE

(Bradyrhizobium
elkanii)
3 / 3 PHE A 151
ARG A 170
ALA A 143
None
0.88A 6ecfB-4k2aA:
16.5
6ecfB-4k2aA:
24.37